Salivary protein factors are elevated in breast cancer patients.
暂无分享,去创建一个
David Elashoff | Yang Li | Jianghuai Wang | D. Elashoff | D. Wong | Yang Li | David T Wong | Jianghua Wang | Mai N Brooks | Rong Zhang | M. Brooks | Rong-hua Zhang
[1] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[2] M. Nguyen. Angiogenic factors as tumor markers , 2004, Investigational New Drugs.
[3] C. Streckfus,et al. The Use of Soluble, Salivary c-erbB-2 for the Detection and Post-operative Follow-up of Breast Cancer in Women: The Results of a Five-year Translational Research Study , 2005, Advances in dental research.
[4] J. Thigpen,et al. A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma , 2000, Cancer investigation.
[5] J. Richie,et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.
[6] W. Dubinsky,et al. Breast Cancer Related Proteins Are Present in Saliva and Are Modulated Secondary to Ductal Carcinoma In Situ of the Breast , 2008, Cancer investigation.
[7] M. Navazesh,et al. Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.
[8] R. Mesía,et al. Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women , 2004, Breast Cancer Research and Treatment.
[9] J. Folkman,et al. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. , 1993, Cancer research.
[10] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[11] L. Fletcher,et al. Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[12] H. Mulcahy,et al. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large‐scale clinical studies? , 2003, International journal of cancer.
[13] A Kingman,et al. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] Ming Lu,et al. Nipple Fluid Basic Fibroblast Growth Factor in Patients with Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[15] E. Kohn,et al. Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] M. Nguyen,et al. Breast-cancer diagnosis with nipple fluid bFGF , 2000, The Lancet.
[17] M. Mildner,et al. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals , 1998, The Journal of pathology.
[18] J. Garst,et al. Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer , 2005, Current oncology reports.
[19] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[20] David Elashoff,et al. Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.
[21] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] F. Kabbinavar,et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.